
Keywords: CAH; congenital adrenal hyperplasia; NBS; newborn screening; TAT; turnaround time; LC-MS/M; liquid chromatography and tandem-mass spectrometry; 17-OHP; 17-hydroxy-progesterone; EDTA; ethylenediaminetetraacetic acid; 21OHyD; 21-hydroxylase deficiency; LoD;